Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "sandoz inc"

Volokh Conspiracy: Paul Hughes on Tuesday's patent law case (Teva Pharmaceuticals v. Sandoz)
Washington Post

Supreme Court Holds Claim Construction Facts Are Subject to Cl...

In Teva Pharm. USA, Inc. v. Sandoz, Inc ., No. 13-854, (U.S., Jan. 20, 2015), the U.S. Supreme Court held that an appellate court must apply a clear error, not de novo , standard of review to the evidentiary underpinnings of a district court's ... National Law Review, 2 hours ago

1 images for "sandoz inc", 1 week ago

Teva patent: Natco suffers setback in US

Natco has teamed up with Mylan, while Novartis AG's generic subsidiary Sandoz Inc. partnered with Momenta Pharmaceuticals Inc. to challenge the validity of Teva's key patent related to 20 mg dosage version of Copaxone in US courts. Photo: Mint ...
 Livemint.com1 week ago US court jolt to Natco  Calcutta Telegraph1 week ago Natco slips 5.9% on US court ruling over Copaxone patent  Business Standard India1 week ago

Helsinn settles with Sandoz over Aloxi in USA

Privately-held Swiss cancer specialist Helsinn Group say it has entered into a settlement agreement with Sandoz Inc, a US generics subsidiary of Swiss pharma major Novartis (NOVN: VX) to resolve their patent litigations relating to Helsinn's Aloxi ...
 Pharma Letter2 weeks ago Helsinn Reaches Settlement Agreement Regarding Patent Dispute on ALOXI┬«  Reliance Trust2 weeks ago Helsinn Healthcare SA Reaches Settlement Agreement Regarding Patent Dispute On ALOXI??  BioSpace2 weeks ago

Sandoz loses bid to shield psoriasis drug

(Reuters) - The top U.S. patent appeals court has upheld the dismissal of a lawsuit brought by Sandoz Inc that sought to shield its planned version of Amgen Inc's psoriasis and arthritis drug Enbrel from patent lawsuits. The ruling, handed down Friday by ...
 Reuters1 month ago

Market Research Reports, Inc. ( Active Pharmaceutical Ingredients (API) Market in India 2015-2019, New Report Launched

Market Research Reports, Inc. has announced the addition of "Active Pharmaceutical Ingredients (API) Market in India 2015-2019" research report to their website Report forecast the API market in India to grow at ...
 BusinessWeek1 week ago Active Pharmaceutical Ingredients (API) Market in India 2015-2019, New Report Launched  Digital Journal1 week ago World OTC Pharmaceuticals Market Forecast 2015-2025  WorldNetDaily3 days ago CINV Existing and Pipeline Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020  CEOWorld Magazine6 days ago

SUPN In Legal Bout, NSPR Put On Notice, It's Advantage TEVA, KTWO Gets FDA Nod

InspireMD Inc. (NSPR: Quote) has been issued a notice of delisting by the NYSE MKT LLC for failure to satisfy continued listing standards of the Exchange. The company reported stockholders' equity of less than $2 million, $4 million, and $6 million ...
 RTTNews.com1 week ago

Astellas Settles Lawsuits Alleging Prograf Generics Delay

Astellas Pharma Inc. (4503) agreed to settle lawsuits over an alleged scheme to delay generic versions of its immune-suppressant drug Prograf, avoiding a trial set to start today. Drug wholesaler plaintiffs and the Tokyo-based company announced ...
 BusinessWeek1 week ago

Arvinas Appoints Manuel Litchman as President and Chief Executive Officer

NEW HAVEN, Conn., Jan. 12, 2015 /PRNewswire/ -- Arvinas Inc., a biotechnology company creating a new class of oncology drugs based on protein degradation, today announced that it has appointed Manuel Litchman, M.D., as President and Chief Executive ...
 BusinessWeek2 weeks ago Arvinas Appoints As President And Chief Executive Officer  BioSpace2 weeks ago NOVARTIS : Arvinas Appoints Manuel Litchman as President and Chief Executive Officer  4 Traders2 weeks ago

Gevo's Victory in Delaware District Court Reinstated

National & World Ag News Headlines USAgNet - 01/28/2015 Gevo, Inc., announced that the U.S. Supreme Court (Supreme Court) ruled in Gevo's favor and overturned an earlier Federal Circuit Court of Appeals (Appeals Court) ruling on the interpretation ...
 USAgNet1 day ago U.S. Supreme Court Rules in Gevo's Favor  Franklin Credit Management Corporation2 days ago Gevo Victory Over Teva in Delaware District Court Reinstated By U.S. Supreme Court  BioFuels Journal9 hours ago Supreme Court rules in Gevo's favor, remands case to lower court  Biomass Magazine1 day ago

Apricus Biosciences Announces Issuance of U.S. Patent for RayVa(TM)

SAN DIEGO, Jan. 27, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ( Nasdaq:APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, announced that today, January 27, 2015, the United States Patent and ...
 Street Sweeper2 days ago APRICUS BIOSCIENCES : Announces Issuance of U.S. Patent for RayVa(TM)  4 Traders2 days ago Apricus Biosciences Files 8K Regulation FD >APRI  iMarketReports2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less